0001535079 false --12-31 2023 Q2 0 0 00015350792023-01-012023-06-30 xbrli:pure 0001535079mccx:UnsecuredPromissoryNoteMembersrt:ChiefFinancialOfficerMember2023-01-23 iso4217:USD xbrli:shares 00015350792022-01-012022-06-30 0001535079mccx:UnsecuredPromissoryNoteMembersrt:ChiefFinancialOfficerMember2023-01-012023-12-31 0001535079mccx:UnsecuredPromissoryNoteMembersrt:ChiefFinancialOfficerMember2022-12-31 0001535079mccx:UnsecuredPromissoryNoteMembersrt:ChiefFinancialOfficerMember2023-01-23 0001535079mccx:UnsecuredPromissoryNoteMembersrt:ChiefExecutiveOfficerMember2023-01-23 0001535079us-gaap:DiscontinuedOperationsDisposedOfBySaleMembermccx:McorpcxMembersrt:ScenarioForecastMember2023-01-012023-12-31 0001535079us-gaap:DiscontinuedOperationsDisposedOfBySaleMembermccx:McorpcxMember2023-06-30 0001535079us-gaap:DiscontinuedOperationsDisposedOfBySaleMembermccx:McorpcxMemberus-gaap:RelatedPartyMember2023-01-012023-06-30 0001535079us-gaap:DiscontinuedOperationsDisposedOfBySaleMembermccx:McorpcxMember2020-08-03 0001535079us-gaap:DiscontinuedOperationsDisposedOfBySaleMembermccx:McorpcxMember2020-04-152020-08-03 00015350792023-06-30 utr:Y iso4217:USDxbrli:shares 00015350792022-12-31 00015350792022-01-012022-12-31 0001535079us-gaap:EmployeeStockOptionMember2016-08-102016-08-10 00015350792016-08-102016-08-10 00015350792008-12-31 00015350792008-01-012008-12-31 00015350792022-06-30 00015350792021-12-31 0001535079us-gaap:RelatedPartyMember2022-01-012022-06-30 0001535079us-gaap:RelatedPartyMember2023-01-012023-06-30 0001535079us-gaap:RetainedEarningsMember2022-06-30 0001535079us-gaap:AdditionalPaidInCapitalMember2022-06-30 0001535079us-gaap:CommonStockMember2022-06-30 00015350792022-04-012022-06-30 0001535079us-gaap:RetainedEarningsMember2022-04-012022-06-30 0001535079us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-30 0001535079us-gaap:CommonStockMember2022-04-012022-06-30 00015350792022-03-31 0001535079us-gaap:RetainedEarningsMember2022-03-31 0001535079us-gaap:AdditionalPaidInCapitalMember2022-03-31 0001535079us-gaap:CommonStockMember2022-03-31 00015350792022-01-012022-03-31 0001535079us-gaap:RetainedEarningsMember2022-01-012022-03-31 0001535079us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-31 0001535079us-gaap:CommonStockMember2022-01-012022-03-31 0001535079us-gaap:RetainedEarningsMember2021-12-31 0001535079us-gaap:AdditionalPaidInCapitalMember2021-12-31 0001535079us-gaap:CommonStockMember2021-12-31 0001535079us-gaap:RetainedEarningsMember2023-06-30 0001535079us-gaap:AdditionalPaidInCapitalMember2023-06-30 0001535079us-gaap:CommonStockMember2023-06-30 00015350792023-04-012023-06-30 0001535079us-gaap:RetainedEarningsMember2023-04-012023-06-30 0001535079us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-30 0001535079us-gaap:CommonStockMember2023-04-012023-06-30 00015350792023-03-31 0001535079us-gaap:RetainedEarningsMember2023-03-31 0001535079us-gaap:AdditionalPaidInCapitalMember2023-03-31 0001535079us-gaap:CommonStockMember2023-03-31 00015350792023-01-012023-03-31 0001535079us-gaap:RetainedEarningsMember2023-01-012023-03-31 0001535079us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-31 0001535079us-gaap:CommonStockMember2023-01-012023-03-31 0001535079us-gaap:RetainedEarningsMember2022-12-31 0001535079us-gaap:AdditionalPaidInCapitalMember2022-12-31 0001535079us-gaap:CommonStockMember2022-12-31 0001535079us-gaap:RelatedPartyMember2022-12-31 0001535079us-gaap:RelatedPartyMember2023-06-30 00015350792023-08-11 thunderdome:item
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2023.

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number:   000-54918

 

MCX TECHNOLOGIES CORPORATION

(Exact name of registrant as specified in its charter)

 

California

(State or other jurisdiction of incorporation or organization)

 

26-0030631

(I.R.S. Employer Identification No.)

 

176 South Capital Blvd.

Boise, Idaho 83702

(Address of principal executive offices, including zip code)

 

208-863-6243

(Registrant's telephone number, including area code)

 

20046 Walker Road

Shaker Heights, OH 44122

(Former address of principal executive offices, including zip code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days. Yes No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer

Accelerated Filer

Non-accelerated Filer

Smaller Reporting Company

   

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

None

N/A

N/A

 

Indicated the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date: 20,426,158 as of August 11, 2023.

 

 

 

 

 

MCX Technologies Corporation

Form 10-Q Quarterly Report

 

TABLE OF CONTENTS

 

   

Page

No.

     
 

Part I. - Financial Information

3

     

Item 1.

Financial Statements.

3

     
 

Consolidated Balance Sheets as of June 30, 2023 (unaudited) and December 31, 2022.

3

     
 

Consolidated Statements of Operations for the three and six months ended June 30, 2023 and 2022 (unaudited).

4

     
 

Consolidated Statements of Changes in Shareholders’ Equity for the three and six months ended June 30, 2023 and 2022 (unaudited).

5

     
 

Consolidated Statements of Cash Flows for the six months ended June 30, 2023 and 2022 (unaudited).

6

     
 

Notes to Consolidated Financial Statements (unaudited).

7

     

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations.

10

     

Item 3.

Quantitative and Qualitative Disclosure about Market Risk.

13

     

Item 4.

Controls and Procedures.

13

     
 

Part II. - Other Information

14

     

Item 1. 

Legal Proceedings.

14

     

Item 1A.

Risk Factors.

14

     

Item 2. 

Unregistered Sales of Equity Securities and Use of Proceeds.

14

     

Item 3. 

Defaults Upon Senior Securities.

14

     

Item 4. 

Mine Safety Disclosures.

14

     

Item 5. 

Other Information.

14

     

Item 6.

Exhibits.

15

     

Signatures

16

 

 

 
 

 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1.     FINANCIAL STATEMENTS.

 

 

 

MCX Technologies Corporation

Consolidated Balance Sheets

 

   

June 30,

   

December 31,

 
   

2023

   

2022

 
   

(unaudited)

         

Assets

               
Current assets:                

Cash and cash equivalents

  $ 30,659     $ 2,595  

Other current assets

    9,937       15,521  

Total current assets

    40,596       18,116  
Long term assets:                

Notes receivable - related party

    115,588       252,738  

Total assets

  $ 156,184     $ 270,854  
                 

Liabilities and Shareholders' Equity

               
Liabilities:                

Accounts payable and accrued liabilities

  $ 109,078     $ 116,497  
Notes payable – related party     20,000       -  

Accrued interest – related party

    574       -  

Total current liabilities

    129,652       116,497  

Total liabilities

    129,652       116,497  
Shareholders' equity:                

Common stock, no par value, 500,000,000 shares authorized, 20,426,158 shares issued and outstanding at June 30, 2023 and December 31, 2022

    -       -  

Additional paid-in capital

    6,620,217       6,620,217  

Accumulated deficit

    (6,593,685

)

    (6,465,860

)

Total shareholders' equity

    26,532       154,357  

Total liabilities and shareholders' equity

  $ 156,184     $ 270,854  

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

3

 

 

 

MCX Technologies Corporation

Consolidated Statements of Operations

(unaudited)

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

 
   

2023

   

2022

   

2023

   

2022

 
                                 

Revenue, net

  $ -     $ 51,488     $ -     $ 92,664  

Cost of goods sold

    -       19,964       -       99,350  

Gross profit (loss)

    -       31,524       -       (6,686 )
Expenses                                

Contract services

    -       -       -       75,212  

Other general and administrative

    38,771       145,409       129,531       219,776  

Total expenses

    38,771       145,409       129,531       294,988  
                                 

Net operating loss

    (38,771

)

    (113,885

)

    (129,531

)

    (301,674 )

Other income (expense)

    829       6,291       1,706       (10,043 )
                                 

Net loss

  $ (37,942

)

  $ (107,594 )   $ (127,825

)

  $ (311,717 )

Loss per share-basic and diluted

  $ (0.00

)

  $ (0.01

)

  $ (0.01

)

  $ (0.02 )
                                 

Weighted average common shares outstanding-basic and diluted

    20,426,158       20,426,158       20,426,158       20,426,158  

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

4

 

 

 

MCX Technologies Corporation

Consolidated Statements of Changes in Shareholders Equity

Three and Six Months Ended June 30, 2023 and 2022

(unaudited)

 

   

Three and Six Months Ended June 30, 2023

 
   

Common Stock

   

Additional

Paid in

   

Accumulated

         
   

Shares

   

Amount

   

Capital

   

Deficit

   

Total

 

Balance at December 31, 2022

    20,426,158     $ -     $ 6,620,217     $ (6,465,860

)

  $ 154,357  

Net loss

    -       -       -       (89,883

)

    (89,883

)

Balance at March 31, 2023

    20,426,158       -       6,620,217       (6,555,743 )     64,474  

Net loss

    -       -       -       (37,942

)

    (37,942

)

Balance at June 30, 2023

    20,426,158     $ -     $ 6,620,217     $ (6,593,685

)

  $ 26,532  

 

 

   

Three and Six Months Ended June 30, 2022

 
   

Common Stock

   

Additional

Paid in

   

Accumulated

         
   

Shares

   

Amount

   

Capital

   

Deficit

   

Total

 

Balance at December 31, 2021

    20,426,158     $ -     $ 6,620,217     $ (6,000,308

)

  $ 619,909  

Net loss

    -       -       -       (204,123

)

    (204,123

)

Balance at March 31, 2022

    20,426,158       -       6,620,217       (6,204,431

)

    415,786  

Net loss

    -       -       -       (107,594

)

    (107,594

)

Balance at June 30, 2022

    20,426,158     $ -     $ 6,620,217     $ (6,312,025

)

  $ 308,192  

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

5

 

 

 

MCX Technologies Corporation

Consolidated Statements of Cash Flows

(unaudited)

 

   

Six Months Ended

 
   

June 30

 
   

2023

   

2022

 
CASH FLOWS FROM OPERATING ACTIVITIES:                

Net loss

  $ (127,825

)

  $ (311,717

)

                 
Adjustments to reconcile net loss to net cash used in operations:                

Gain on the sale of land

    -       (1,530 )
Changes in operating assets and liabilities:                

Accounts receivable

    -       130,874  

Other current assets

    5,584       -  

Accounts payable and accrued liabilities

    (6,845

)

    (59,312 )
                 

Net cash used in operating activities

    (129,086

)

    (241,685

)

                 
INVESTING ACTIVITIES                

Cash received from sale of land

    -       86,530  

Cash received from notes receivable - related party

    137,150       117,799  
                 

Net cash provided by investing activities

    137,150       204,329  
                 
FINANCING ACTIVITIES                

Proceeds from notes payable – related party

    20,000       -  

Net cash provided by financing activities

    20,000       -  
                 
Decrease in cash and cash equivalents     28,064       (37,356

)

                 
Cash and cash equivalents, beginning of period     2,595       51,393  
                 

Cash and cash equivalents, end of period

  $ 30,659     $ 14,037  
                 
Supplemental disclosure of cash flow information:                

Cash paid for interest

  $ -     $ -  

Cash paid for income taxes

    -       -  

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

6

 

 

MCX TECHNOLOGIES CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2023

(unaudited)

 

 

 

 

Note 1: Organization and Basis of Presentation

 

MCX Technologies Corporation (“we,” “us,” “our,” or the “Company”) intends to acquire or develop technologies that would become the Company’s new operating platform. During the first six months of 2022, through our subsidiary, The Collective Experience LLC (the “Collective Experience”), we generated revenue by delivering digital transformation solutions to customer centric organizations through integrated marketing, data science, and commerce. We are now transitioning the focus of the Company toward new technologies. The Company operated as The Innes Group, Inc., d/b/a MCorp Consulting until filing a Certificate of Amendment to the Articles of Incorporation renaming the Company Touchpoint Metrics, Inc., effective October 18, 2011. During Q1 2015, the Company filed a d/b/a (doing business as) with the State of California Secretary of State to begin doing business as McorpCX. On June 11, 2015, at our Annual General Meeting, shareholders passed a resolution to change the name of the Company to McorpCX, Inc. On June 29, 2020, at our Annual General Meeting, in connection with the sale of McorpCX, LLC, shareholders passed a resolution to change the name of the Company to MCX Technologies Corporation. On November 12, 2020, the Company formed the Collective Experience in Delaware. As of April 1, 2022 MCX will no longer be signing new client engagements within the Collective Experience as we are not pursuing that segment in order to focus on Web 3 technologies and powering the Metaverse.

 

The consolidated financial statements and related disclosures as of and for the three and six months ended June 30, 2023, are unaudited, pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC"). The consolidated balance sheet as of December 31, 2022 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. In our opinion, these consolidated financial statements include all adjustments (consisting only of normal recurring adjustments) necessary for the fair statement of the results for the interim periods. These consolidated financial statements should be read in conjunction with the consolidated financial statements included in our Annual Report for the year ended December 31, 2022, filed on Form 10-K with the SEC on March 31, 2023. The results of operations for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the full year.

 

 

Note 2: Recent Accounting Pronouncements

 

In June 2016, the Financial Accounting Standards Board issued ASU No. 2016-13, "Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" and subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04 and ASU 2019-05 (collectively, “Topic 326”). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. The Company adopted Topic 326 on January 1, 2021 and the adoption had no impact on the Company’s consolidated financial statements. The Company reviewed other newly issued accounting pronouncements and concluded that they either are not applicable to the Company's operations or that no material effect is expected on the Company's financial statements upon future adoption.

 

7

 

 

 

Note 3: Stock-Based Compensation

 

Our stock-based compensation plan was originally established in 2008. The shares of our common stock issuable pursuant to the terms of such plan (the “Plan Shares”) could not exceed 30% of any outstanding issue or 2,500,000 shares, whichever was the lower amount.

 

In December 2015, we adopted a revised share option plan in which Plan Shares cannot exceed 10% of the total issued and outstanding shares at any given time. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of the grant and all option grants have a 10-year term. This share option plan was initially approved by the Company’s shareholders at the annual meeting of shareholders on August 10, 2016 and is required to be re-approved at each subsequent annual meeting of the Company’s stockholders since that date, in accordance with applicable TSX-V rules.

 

To calculate the fair value of stock options at the date of grant, we use the Black-Scholes option pricing model. The volatility used is based on a blended historical volatility of our own stock and similar sized companies due to the limited historical data available for our own stock price. The expected term was determined based on the simplified method outlined in Staff Accounting Bulletin No. 110. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

 

8

 

 

The following table summarizes our stock option activity for the six months ended June 30, 2023:

 

           

Weighted

   

Average

         
           

Average

   

Remaining

   

Aggregate

 
   

Number of

   

Exercise

   

Contractual

   

Intrinsic

 
   

Shares

   

Price

   

Term (in years)

   

Value

 

Outstanding at December 31, 2022

    690,000     $ 0.23       2.63       -  

Granted

    -                          

Exercised

    -                          

Forfeited or expired

    -                          

Outstanding at June 30, 2023

    690,000     $ 0.23       2.20     $ -  
                                 

Exercisable at June 30, 2023

    690,000     $ 0.23       2.20     $ -  

 

As of June 30, 2023, 690,000 stock options were exercisable and all were vested. There was no unrecognized compensation expense from stock options as of June 30, 2023.

 

There were no options granted during the six months ended June 30, 2023.

 

 

 

Note 4: Going Concern

 

The accompanying consolidated financial statements and notes have been prepared assuming that the Company will continue as a going concern.

 

We have had material operating losses and have not yet created positive cash flows for a full fiscal year. These factors raise substantial doubt as to our ability to continue as a going concern.

 

On August 3, 2020, the Company completed the sale of all of the membership interests in McorpCX, LLC, from which it received proceeds of $1,108,000, consisting of $352,000 in cash and a $756,000 promissory note, reflected on the Company’s financial statements as a “note receivable – related party”. Pursuant to the note receivable, the Company has received $20,000 monthly payments of principal and interest from the purchaser of McorpCX, LLC, which we have relied on to fund our operating costs. As of June 30, 2023, the balance on the note receivable, which matures on December 31, 2023, is $115,588. The $20,000 monthly payments to the Company under the note receivable will end on December 31, 2023.

 

On January 23, 2023 the Company borrowed $20,000 from Gregg Budoi, Interim Chief Financial Officer, and entered into an unsecured Promissory Note that bears interest at the rate of 7%. The accrued interest and outstanding principal balance is due in one lump sum on September 20, 2023.

 

After payment on September 30, 2023 of the $20,000 due under the unsecured Promissory Note, plus accrued interest, held by our Interim Chief Financial Officer, and without the $20,000 in monthly income from the note receivable which ceases on December 31, 2023, the Company believes it does not have sufficient capital to cover our operating costs for the next 12 months, and is seeking ways to raise capital to support operating costs for that period. Therefore, our ability to continue as a going concern is entirely dependent upon our ability over the next 12 months to achieve a level of profitability, and/or to raise additional capital through debt financing and/or through sales of common stock. We cannot provide any assurance that profits from operations, if any, will generate sufficient cash flow to meet our working capital needs and service our existing obligations, nor that sufficient capital can be raised through debt or equity financing. The consolidated financial statements do not include adjustments related to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should we be unable to continue as a going concern.

 

 

 

Note 5: Basic and Diluted Net Income / (Loss) per Share

 

Net income (loss) per share was computed by dividing the net income (loss) by the weighted average number of common shares outstanding during the period. The weighted average number of shares was calculated by taking the number of shares outstanding and weighting them by the amount of time that they were outstanding. For the three and six months ended June 30, 2023 and 2022, the assumed exercise of share options is anti-dilutive and are excluded from the determination of net income (loss) per share – basic and diluted. The share options were anti-dilutive due to the Company’s net loss or the Company’s common stock average market price was less than the share options exercise price. Accordingly, net income/(loss) per share basic and diluted are equal in all periods presented. Securities that were not included in the diluted per share calculations because they would be anti-dilutive were options to purchase common stock of 690,000 and 690,000 for the six months ended June 30, 2023 and 2022, respectively.

 

 

 

Note 6: Related Party Transaction

 

On January 23, 2023 the Company borrowed $20,000 from the Interim Chief Financial Officer and entered into an unsecured Promissory Note that bears interest at the rate of 7%. The accrued interest and outstanding principal balance is due in one lump sum on September 20, 2023.

 

9

 

 

 

ITEM 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

Cautionary Statement

 

This Management’s Discussion and Analysis includes a number of forward-looking statements that reflect our current views with respect to future events and financial performance. Forward-looking statements are often identified by words like: “believe,” “expect,” “plan”, “estimate,” “anticipate,” “intend,” “project,” “will,” “predicts,” “seeks,” “may,” “would,” “could,” “potential,” “continue,” “ongoing,” “should” and similar expressions, or words which, by their nature, refer to future events. You should not place undue certainty on these forward-looking statements, which apply only as of the date of this Form 10-Q. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or from our predictions. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events, or otherwise.

 

Unless the context otherwise requires, all references to “we,” “us,” “our” or the “Company” are to MCX Technologies Corporation and our subsidiaries.

 

Critical Accounting Policies and Estimates

 

Our financial statements are prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Our actual results could differ from these estimates. We believe that the assumptions and estimates associated with revenue recognition, income taxes, stock-based compensation, research and development costs and impairment of long-lived assets have the greatest potential impact on our financial statements. Therefore, we consider these to be our critical accounting policies and estimates.

 

A description of the Company’s critical accounting policies and related judgments and estimates that affect the preparation of the Company’s financial statements is set forth in under the heading “Critical Accounting Policies and Estimates” in Item 7, Management’s Discussion and Analysis of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Such policies were unchanged during the six months ended June 30, 2023.

 

Overview

 

We intend to acquire or develop technologies that would become the Company’s new operating platform.

 

On November 12, 2020, the Company formed a subsidiary, The Collective Experience, LLC in Delaware (the “Collective Experience”). During the first six months of 2022, through the Collective Experience, we generated revenue by delivering digital transformation solutions to customer centric organizations through integrated marketing, data science, and commerce. We are now transitioning the focus of the Company toward new technologies.

 

The Company formed a wholly owned subsidiary, McorpCX, LLC (“McorpCX LLC”) as a limited liability company in the state of Delaware on December 14, 2017. On August 16, 2018, the Company entered into a contribution agreement with McorpCX LLC pursuant to which the Company transferred to McorpCX LLC all the Company’s assets and liabilities related to the Company’s customer experience consulting business, excluding the underlying technology and databases related thereto which remained with the Company.

 

Effective August 3, 2020, the Company sold all of its membership interests in McorpCX, LLC to mfifty, LLC, a California limited liability company controlled by Michael Hinshaw, the then current President of McorpCX LLC (the “Purchaser”). Since the Company’s professional and related consulting services business, which constituted substantially all of the Company’s operations at the time of the sale of McorpCX LLC, was conducted through McorpCX LLC, the sale of McorpCX LLC represented a strategic shift that had a major effect on the Company’s operations and financial results.

 

As consideration for the sale of McorpCX LLC, the Company received a total of $352,000 in cash consisting of $100,000 received upon the signing of the purchase agreement and $252,000 received at the closing of the transaction along with a $756,000 promissory note, reflected on the Company's financial statements as “note receivable – related party”. The promissory note has an initial annual interest rate of 0.99% (to be recalculated at the end of each twelve-month period subsequent to the date of the note based on the annual Applicable Federal Rate for mid-term loans on the first business day following each such twelve-month period) accruing daily on the outstanding balance of the note, and monthly principal payments are payable to the Company over a term of four or more years. Monthly principal payments to the Company were initially $7,292 per month for the first twelve months following the date of the note, and then during each subsequent twelve-month period are based on the annual revenues of McorpCX, LLC. On June 11, 2021, the Company and the Purchaser entered into an amendment to the promissory note whereby the Purchaser agreed to pay the Company One Hundred Thousand Dollars ($100,000) on or before July 1, 2021 to be applied towards the outstanding principal amount of the promissory note and then going forward to pay the remaining principal amount in installments of Twenty Thousand Dollars ($20,000) each due on the first day of each month commencing on August 1, 2021 until the principal amount is paid in full, with the final payment being the remaining unpaid outstanding balance due at that time. The scheduled maturity date of the note, as amended, is December 31, 2023. The amendment to the promissory note also provides that the promissory note will be considered paid in full if any of the following occurs: (i) the Purchaser pays at least 90% of the outstanding balance due (principal and interest) under the promissory note by December 31, 2021; (ii) the Purchaser pays at least 95% of the outstanding balance due under the promissory note by June 30, 2022; and (iii) the Purchaser pays at least 97.5% of the outstanding balance due (principal and interest) under the promissory note by December 31, 2022. The Company has received a total of $679,378 as of the date of this report. The note is secured by the Purchaser's ownership interest in McorpCX LLC.

 

10

 

 

Sources of Revenue

 

Prior to the sale of McorpCX, LLC in August 2020, our revenue consisted primarily of fees from professional and consulting services and other revenue primarily related to the reimbursement of expenses mostly through the operations of McorpCX LLC. Product revenue was from productized and software-enabled service sales not elsewhere classified.

 

As of April 1, 2022, MCX no longer has been signing new client engagements within the Collective Experience as we are not pursuing that segment in order to focus on a new technology platform which may include Web 3 technologies and powering the Metaverse. As of June 30, 2023, we do not have a revenue source and continue to seek a new technology platform that will be the basis for further revenue and profitability.

 

 

Operating Expenses

 

Cost of Goods Sold

 

Cost of goods sold consist primarily of expenses directly related to providing professional and consulting services. Those expenses include contract labor, third-party services, and materials and travel expenses related to providing professional services to our clients.

 

General and Administrative Expenses 

 

General and administrative expenses consist primarily of finance and accounting, software subscriptions, insurance, stock compensation expense, client delivery, and sales and marketing. These expenses also include contract services, as well as marketing and promotion costs, professional fees, software license fee expenses, administrative costs, insurance, rent and a portion of travel expenses and other overhead, which are categorized as “other general and administrative expenses” in our consolidated financial statements. In addition, the other general and administrative expenses include the professional fees, filing, and registration costs necessary to meet the requirements associated with having to file reports with the United States Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, as well as having our stock listed on the TSX Venture Exchange in Canada and quoted on the OTC Pink Sheets in the United States.

 

11

 

 

Results of Operations

 

Revenues and Cost of Goods Sold

 

During the three and six months ended June 30, 2023, we had no revenue recognized as well as no related cost of goods sold.

 

During the three and six months ended June 30, 2022, we had $51,488 and $92,664, respectively, in revenue recognized as well as the related cost of goods sold of $19,964 and $99,350, respectively, generated through the continuation of one client contract that was entered into in the last quarter of 2021.

 

                   

Change from

   

Percent Change

 

Net Loss

 

2023

   

2022

   

Prior Year

   

from Prior Year

 

Three Months Ended June 30,

  $ (37,942

)

  $ (107,594 )   $ 69,652       (65

%)

Six Months Ended June 30,

  $ (127,825

)

  $ (311,717 )   $ 183,892       (59

%)

 

Net loss decreased to $37,942 for the three months ended June 30, 2023 from a net loss of $107,594 for the three months ended June 30, 2022 mostly as a result of a decrease in operating expenses incurred during the three months ended June 30, 2023.

 

Net loss decreased to $127,825 for the six months ended June 30, 2023 from a net loss of $311,717 for the six months ended June 30, 2022 mostly as a result of a decrease in operating expenses incurred during the six months ended June 30, 2023.

 

                   

Change from

   

Percent Change

 

Contract Services

 

2023

   

2022

   

Prior Year

   

from Prior Year

 

Three Months Ended June 30,

  $ -     $ -     $ -       -  

Six Months Ended June 30,

  $ -     $ 75,212     $ (75,212 )     (100

%)

 

Contract service expenses decreased during the six months ended June 30, 2023, due to management eliminating the business line performed by its subsidiary The Collective Experience LLC. While the Company is transitioning to a new technology platform, we have classified all executive, finance, and administrative services under Other General and Administrative expense.

 

                   

Change from

   

Percent Change

 

Other General and Administrative

 

2023

   

2022

   

Prior Year

   

from Prior Year

 

Three Months Ended June 30,

  $ 38,771     $ 145,409     $ (106,638 )     (73

%)

Six Months Ended June 30,

  $ 129,531     $ 219,776     $ (90,245 )     (41

%)

 

Other general and administrative costs decreased by $106,638 and $90,245 during the three and six months ended June 30, 2023, respectively, compared with the same periods in 2022 primarily due to a decrease in sales and marketing, professional fees and travel expenses in 2023 compared to 2022.

 

                   

Change from

   

Percent Change

 

Other Income (Expense)

 

2023

   

2022

   

Prior Year

   

from Prior Year

 

Three Months Ended June 30,

  $ 829     $ 6,291     $ (5,462 )     (87

%)

Six Months Ended June 30,

  $ 1,706     $ (10,043 )   $ 11,749       (117

%)

 

Other income was $829 and $1,706 in the three and six months ended June 30, 2023, respectively, compared to other income of $6,291 and other expenses of ($10,043) in the three and six months ended June 30, 2022, respectively, due to reduced other income from the prior year coupled with a decrease in non-recurring other expenses.

 

Liquidity and Capital Resources

 

We measure our liquidity in a variety of ways, including the following:

 

   

June 30,

   

December 31,

 
   

2023

   

2022

 

Cash and cash equivalents

  $ 30,659     $ 2,595  

Working capital

  $ (89,056

)

  $ (98,381 )

 

Anticipated Uses of Cash

 

As of June 30, 2023, our cash and cash equivalents had increased to $30,659 from $2,595 and our working capital changed to ($89,056) from ($98,381) as of December 31, 2022.

 

12

 

 

We received total consideration of $1,108,000 consisting of $352,000 in cash and a $756,000 promissory note for the sale of McorpCX, LLC, which was completed on August 3, 2020, which applied to transaction costs as well as investment toward becoming a technology solutions business. For the six months ended June 30, 2023, we were able to finance our operations with cash generated through cash on hand as well as $20,000 monthly payments we receive under the note receivable related to the sale of McorpCX, LLC. The accompanying consolidated financial statements have been prepared in accordance with GAAP applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.

 

The note receivable matures on December 31, 2023 and the $20,000 monthly payments to the Company will cease after that date. The Company is exploring ways to minimize its cash outflow to allow for the remaining payments of the notes receivable plus its current cash on hand to fund operations for the next 12 months. However, without this monthly income, the Company projects that all available cash will go to payment of operating expenses and that it does not have sufficient capital to cover operating costs for the next 12 months.  We are seeking ways to raise capital to support operating costs for that period. Our ability to continue as a going concern is entirely dependent upon our ability during the next 12 months to achieve a level of profitability, and/or to raise additional capital through debt financing and/or through sales of common stock. We cannot provide any assurance that profits from operations, if any, will generate sufficient cash flow to meet our working capital needs and service our existing obligations, nor that sufficient capital can be raised through debt or equity financing. The consolidated financial statements do not include adjustments related to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should we be unable to continue as a going concern.

 

During the six months ended June 30, 2023, our primary uses of cash included third party contractors to support our consulting services, and general and administrative expenses to support new business development activities.

 

We do not intend to pay dividends in the foreseeable future.

 

We intend to continue to seek ways to continue as a going concern and expand upon our business and as such, in the future we may make acquisitions of businesses or assets or commitments to additional capital projects. To achieve the long-term goals of expanding our assets and earnings, including through acquisitions, capital resources will be required. Depending on the size of a transaction, the capital resources that may be required can be substantial. The necessary resources may be generated from cash flow from operations, cash on hand, the proceeds of the sale of McorpCX, LLC, borrowing or the issuance of securities, and there is no assurance these capital resources will be available to us when required.

 

Cash Flow Six months ended June 30, 2023 and 2022

 

Operating Activities. Net cash used in operating activities decreased to $129,086 for the six months ended June 30, 2023 compared to net cash used in operating activities of $241,685 for the six months ended June 30, 2022. This decrease was primarily due a decrease in net loss and a decrease in cash used for accounts payable and accrued liabilities, offset by a decrease in cash from accounts receivable.

 

Investing Activities. Net cash provided by investing activities was $137,150 for the six months ended June 30, 2023. This included cash received from notes receivable – related party of $137,150. There was cash provided by investing activities of $204,329 for the six months ended June 30, 2022 due to cash received from related party notes receivable of $117,799 and cash received from the sale of land for $86,530.

 

Financing Activities. For the six months ended June 30, 2023, net cash provided by financing activities was $20,000 which includes cash received from an unsecured loan to the company from the Interim Chief Financial Officer in the amount of $20,000. There was no cash provided by, or used in, financing activities for the six months ended June 30, 2022.

 

 

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and as such, are not required to provide the associated information under this item.

 

ITEM 4.

CONTROLS AND PROCEDURES.

 

Disclosure Controls and Procedure

 

Pursuant to Rule 13a-15(b) and Rule 15d-15(b) under the Exchange Act, the Company carried out an evaluation, with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the Company’s disclosure controls and procedures (as defined under Rule 13a-15I or Rule 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, the Company’s management concluded that, as of the period covered by this report, and as reported in Item 9A of the Company’s Form 10-K for the year ended December 31, 2022, the Company’s disclosure controls and procedures were not effective to ensure that information required to be disclosed by the Company in the reports that the Company files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding required disclosure.

 

It should be noted that any system of controls is based in part upon certain assumptions designed to obtain reasonable (and not absolute) assurance as to its effectiveness, and there can be no assurance that any design will succeed in achieving its stated goals.

 

13

 

 

Changes in Internal Controls

 

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II. OTHER INFORMATION

 

ITEM 1.

LEGAL PROCEEDINGS.

 

We are not involved in any legal actions or claims and to our knowledge no such actions or claims are pending.

 

ITEM 1A.

RISK FACTORS.

 

In addition to the other information set forth in this Quarterly Report (including risks associated with our liquidity and our shift away from the Collective Experience to focus on new technologies), you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “2022 Annual Report”), which could materially affect our business, results of operations or financial condition. 

 

It is important to note that the risks described in our 2022 Annual Report are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may eventually prove to materially adversely affect our business, results of operations or financial condition.

 

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

Recent Sales of Unregistered Securities

 

There were no unregistered sales of our equity securities during the six month period ended on June 30, 2023.

 

Purchases of Equity Securities

 

During the six months ended June 30, 2023 there were no purchases of our common stock made by, or on behalf of, the Company or a“y "affiliated purchas”r," as defined by Rule 10b-18 of the Exchange Act.

 

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4.

MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5.

OTHER INFORMATION.

 

(a)

Not applicable.

 

14

 

 

ITEM 6.

EXHIBITS. 

 

3.1

Articles of Incorporation (Incorporated by reference to Exhibit 3.1 to the Companys Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012)

3.2

Amendment to the Articles of Incorporation (Incorporated by reference to Exhibit 3.2 to the Companys Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).

3.3

Amendment to the Articles of Incorporation (Incorporated by reference to Exhibit 3.3 to the Companys Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).

3.4

Amendment to the Articles of Incorporation (Incorporated by reference to the Companys Form 8-K filed with the Securities and Exchange Commission on July 13, 2015).

3.5

Amendment to the Articles of Incorporation (Incorporated by reference to the Companys Form 10-Q filed with the Securities and Exchange Commission on November 14, 2016).

3.6

Amendments to the Articles of Incorporation (Incorporated by reference to the Companys Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020).

3.7 

Amended and Restated Bylaws.(Incorporated by reference to the Companys Form 10-Q filed with the Securities and Exchange Commission on November 16, 2020).

31.1

Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).

31.2

Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).

32.1*

Certification of Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350

32.2*

Certification of Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350

 

101

The following financial information from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in Inline Extensible Business Reporting Language (XBRL): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations; (iii) Consolidated Statements of Changes in Shareholders’ Equity; (iv) Consolidated Statements of Cash Flows; and (iv) Notes to Consolidated Financial Statements, tagged as blocks of text.

104

The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in Inline XBRL (included as Exhibit 101).

 

*Furnished, not filed

 

15

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report has been signed on its behalf by the undersigned, thereunto duly authorized on this 11th day of August 2023.

 

 

MCX TECHNOLOGIES CORPORATION

 
     
     
 

BY:

/s/ Christopher Rowlison

 
   

Christopher Rowlison

 
   

Chief Executive Officer

 
       
 

BY:

/s/ Gregg Budoi

 
   

Gregg Budoi

 
   

Interim Chief Financial Officer

 

 

16

 

 

EXHIBIT INDEX

 

3.1

Articles of Incorporation (Incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).

3.2

Amendment to the Articles of Incorporation (Incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).

3.3

Amendment to the Articles of Incorporation (Incorporated by reference to Exhibit 3.3 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).

3.4

Amendment to the Articles of Incorporation (Incorporated by reference to the Company’s Form 8-K filed with the Securities and Exchange Commission on July 13, 2015).

3.5

Amendment to the Articles of Incorporation (Incorporated by reference to the Company’s Form 10-Q filed with the Securities and Exchange Commission on November 14, 2016).

3.6

Amendments to the Articles of Incorporation (Incorporated by reference to the Company’s Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020).

3.7 

Amended and Restated Bylaws (Incorporated by reference to the Company’s Form 10-Q filed with the Securities and Exchange Commission on November 16, 2020). 

31.1

Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).

31.2

Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).

32.1*

Certification of Chief Executive Officer and Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350

32.2*

Certification of Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350

 

101

The following financial information from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in Inline Extensible Business Reporting Language (XBRL): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations; (iii) Consolidated Statements of Changes in Shareholders’ Equity; (iv) Consolidated Statements of Cash Flows; and (iv) Notes to Consolidated Financial Statements, tagged as blocks of text.

104

The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in Inline XBRL (included as Exhibit 101).

 

*Furnished, not filed

 

17

 

Exhibit 31.1

 

SARBANES-OXLEY SECTION 302(a) CERTIFICATION

 

I, Christopher Rowlison, certify that:

 

1.

I have reviewed this Form 10-Q for the quarterly period ended June 30, 2023 of MCX Technologies Corporation;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

   

 

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

   

 

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

   

 

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

   

 

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date:  August 11th, 2023

/s/ Christopher Rowlison

 

Christopher Rowlison

 

Chief Executive Officer

 

 

 

Exhibit 31.2

 

SARBANES-OXLEY SECTION 302(a) CERTIFICATION

 

I, Gregg Budoi, certify that:

 

1.

I have reviewed this Form 10-Q for the quarterly period ended June 30, 2023 of MCX Technologies Corporation;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

   

 

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

   

 

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

   

 

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

   

 

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date:  August 11th, 2023

/s/ Gregg Budoi

 

Gregg Budoi

 

Interim Chief Financial Officer

 

 

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the Quarterly Report of MCX Technologies Corporation (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Christopher Rowlison, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

     
 

(2)

The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated this 11th day of August, 2023.

 

 

/s/ Christopher Rowlison

 

Christopher Rowlison

 

Chief Executive Officer

 

 

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the Quarterly Report of MCX Technologies Corporation (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gregg Budoi, Interim Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

     
 

(2)

The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated this 11th day of August, 2023. 

 

/s/ Gregg Budoi

 

Gregg Budoi

 

Interim Chief Financial Officer

 

 
v3.23.2
Document And Entity Information - shares
6 Months Ended
Jun. 30, 2023
Aug. 11, 2023
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2023  
Document Transition Report false  
Entity File Number 000-54918  
Entity Registrant Name MCX TECHNOLOGIES CORPORATION  
Entity Incorporation, State or Country Code CA  
Entity Tax Identification Number 26-0030631  
Entity Address, Address Line One 176 South Capital Blvd.  
Entity Address, City or Town Boise  
Entity Address, State or Province ID  
Entity Address, Postal Zip Code 83702  
City Area Code 208  
Local Phone Number 863-6243  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   20,426,158
Entity Central Index Key 0001535079  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q2  
Amendment Flag false  
v3.23.2
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 30,659 $ 2,595
Other current assets 9,937 15,521
Total current assets 40,596 18,116
Long term assets:    
Total assets 156,184 270,854
Liabilities:    
Accounts payable and accrued liabilities 109,078 116,497
Total current liabilities 129,652 116,497
Total liabilities 129,652 116,497
Shareholders' equity:    
Common stock, no par value, 500,000,000 shares authorized, 20,426,158 shares issued and outstanding at March 31, 2023 and December 31, 2022 0 0
Additional paid-in capital 6,620,217 6,620,217
Accumulated deficit (6,593,685) (6,465,860)
Total shareholders' equity 26,532 154,357
Total liabilities and shareholders' equity 156,184 270,854
Related Party [Member]    
Long term assets:    
Notes receivable - related party 115,588 252,738
Liabilities:    
Note payable – related party 20,000 0
Accrued interest – related party $ 574 $ 0
v3.23.2
Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares
$ / shares in Thousands
Jun. 30, 2023
Dec. 31, 2022
Common stock, par value (in dollars per share) $ 0 $ 0
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common Stock, Shares, Issued (in shares) 20,426,158 20,426,158
Common stock, shares outstanding (in shares) 20,426,158 20,426,158
v3.23.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenue, net $ 0 $ 51,488 $ 0 $ 92,664
Cost of goods sold 0 19,964 0 99,350
Gross profit (loss) 0 31,524 0 (6,686)
Expenses        
Contract services 0 0 0 75,212
Other general and administrative 38,771 145,409 129,531 219,776
Total expenses 38,771 145,409 129,531 294,988
Net operating loss (38,771) (113,885) (129,531) (301,674)
Other income (expense) 829 6,291 1,706 (10,043)
Net loss $ (37,942) $ (107,594) $ (127,825) $ (311,717)
Net loss per share-basic and diluted:        
Loss per share-basic and diluted (in dollars per share) $ (0.00) $ (0.01) $ (0.01) $ (0.02)
Weighted average common shares outstanding-basic and diluted (in shares) 20,426,158 20,426,158 20,426,158 20,426,158
v3.23.2
Consolidated Statements of Changes In Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2021 20,426,158      
Balance at Dec. 31, 2021 $ 0 $ 6,620,217 $ (6,000,308) $ 619,909
Net loss $ 0 0 (204,123) (204,123)
Balance (in shares) at Mar. 31, 2022 20,426,158      
Balance at Mar. 31, 2022 $ 0 6,620,217 (6,204,431) 415,786
Balance (in shares) at Dec. 31, 2021 20,426,158      
Balance at Dec. 31, 2021 $ 0 6,620,217 (6,000,308) 619,909
Net loss       (311,717)
Balance (in shares) at Jun. 30, 2022 20,426,158      
Balance at Jun. 30, 2022 $ 0 6,620,217 (6,312,025) 308,192
Balance (in shares) at Mar. 31, 2022 20,426,158      
Balance at Mar. 31, 2022 $ 0 6,620,217 (6,204,431) 415,786
Net loss $ 0 0 (107,594) (107,594)
Balance (in shares) at Jun. 30, 2022 20,426,158      
Balance at Jun. 30, 2022 $ 0 6,620,217 (6,312,025) $ 308,192
Balance (in shares) at Dec. 31, 2022 20,426,158     20,426,158
Balance at Dec. 31, 2022 $ 0 6,620,217 (6,465,860) $ 154,357
Net loss $ 0 0 (89,883) (89,883)
Balance (in shares) at Mar. 31, 2023 20,426,158      
Balance at Mar. 31, 2023 $ 0 6,620,217 (6,555,743) $ 64,474
Balance (in shares) at Dec. 31, 2022 20,426,158     20,426,158
Balance at Dec. 31, 2022 $ 0 6,620,217 (6,465,860) $ 154,357
Net loss       $ (127,825)
Balance (in shares) at Jun. 30, 2023 20,426,158     20,426,158
Balance at Jun. 30, 2023 $ 0 6,620,217 (6,593,685) $ 26,532
Balance (in shares) at Mar. 31, 2023 20,426,158      
Balance at Mar. 31, 2023 $ 0 6,620,217 (6,555,743) 64,474
Net loss $ 0 0 (37,942) $ (37,942)
Balance (in shares) at Jun. 30, 2023 20,426,158     20,426,158
Balance at Jun. 30, 2023 $ 0 $ 6,620,217 $ (6,593,685) $ 26,532
v3.23.2
Consolidated Statements of Changes In Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2021 20,426,158      
Balance at Dec. 31, 2021 $ 0 $ 6,620,217 $ (6,000,308) $ 619,909
Net loss $ 0 0 (204,123) (204,123)
Balance (in shares) at Mar. 31, 2022 20,426,158      
Balance at Mar. 31, 2022 $ 0 6,620,217 (6,204,431) 415,786
Balance (in shares) at Dec. 31, 2021 20,426,158      
Balance at Dec. 31, 2021 $ 0 6,620,217 (6,000,308) 619,909
Net loss       (311,717)
Balance (in shares) at Jun. 30, 2022 20,426,158      
Balance at Jun. 30, 2022 $ 0 6,620,217 (6,312,025) 308,192
Balance (in shares) at Mar. 31, 2022 20,426,158      
Balance at Mar. 31, 2022 $ 0 6,620,217 (6,204,431) 415,786
Net loss $ 0 0 (107,594) (107,594)
Balance (in shares) at Jun. 30, 2022 20,426,158      
Balance at Jun. 30, 2022 $ 0 6,620,217 (6,312,025) $ 308,192
Balance (in shares) at Dec. 31, 2022 20,426,158     20,426,158
Balance at Dec. 31, 2022 $ 0 6,620,217 (6,465,860) $ 154,357
Net loss $ 0 0 (89,883) (89,883)
Balance (in shares) at Mar. 31, 2023 20,426,158      
Balance at Mar. 31, 2023 $ 0 6,620,217 (6,555,743) $ 64,474
Balance (in shares) at Dec. 31, 2022 20,426,158     20,426,158
Balance at Dec. 31, 2022 $ 0 6,620,217 (6,465,860) $ 154,357
Net loss       $ (127,825)
Balance (in shares) at Jun. 30, 2023 20,426,158     20,426,158
Balance at Jun. 30, 2023 $ 0 6,620,217 (6,593,685) $ 26,532
Balance (in shares) at Mar. 31, 2023 20,426,158      
Balance at Mar. 31, 2023 $ 0 6,620,217 (6,555,743) 64,474
Net loss $ 0 0 (37,942) $ (37,942)
Balance (in shares) at Jun. 30, 2023 20,426,158     20,426,158
Balance at Jun. 30, 2023 $ 0 $ 6,620,217 $ (6,593,685) $ 26,532
v3.23.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (127,825) $ (311,717)
Adjustments to reconcile net loss to net cash used in operations:    
Gain on the sale of land 0 (1,530)
Changes in operating assets and liabilities:    
Accounts receivable 0 130,874
Other current assets 5,584 0
Accounts payable and accrued liabilities (6,845) (59,312)
Net cash used in operating activities (129,086) (241,685)
INVESTING ACTIVITIES    
Cash received from sale of land 0 86,530
Net cash provided by investing activities 137,150 204,329
FINANCING ACTIVITIES    
Net cash provided by financing activities 20,000 0
Decrease in cash and cash equivalents 28,064 (37,356)
Cash and cash equivalents, beginning of period 2,595 51,393
Cash and cash equivalents, end of period 30,659 14,037
Supplemental disclosure of cash flow information:    
Cash paid for interest 0 0
Cash paid for income taxes 0 0
Related Party [Member]    
INVESTING ACTIVITIES    
Cash received from notes receivable - related party 137,150 117,799
FINANCING ACTIVITIES    
Proceeds from notes payable – related party $ 20,000 $ 0
v3.23.2
Note 1 - Organization and Basis of Presentation
6 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

Note 1: Organization and Basis of Presentation

 

MCX Technologies Corporation (“we,” “us,” “our,” or the “Company”) intends to acquire or develop technologies that would become the Company’s new operating platform. During the first six months of 2022, through our subsidiary, The Collective Experience LLC (the “Collective Experience”), we generated revenue by delivering digital transformation solutions to customer centric organizations through integrated marketing, data science, and commerce. We are now transitioning the focus of the Company toward new technologies. The Company operated as The Innes Group, Inc., d/b/a MCorp Consulting until filing a Certificate of Amendment to the Articles of Incorporation renaming the Company Touchpoint Metrics, Inc., effective October 18, 2011. During Q1 2015, the Company filed a d/b/a (doing business as) with the State of California Secretary of State to begin doing business as McorpCX. On June 11, 2015, at our Annual General Meeting, shareholders passed a resolution to change the name of the Company to McorpCX, Inc. On June 29, 2020, at our Annual General Meeting, in connection with the sale of McorpCX, LLC, shareholders passed a resolution to change the name of the Company to MCX Technologies Corporation. On November 12, 2020, the Company formed the Collective Experience in Delaware. As of April 1, 2022 MCX will no longer be signing new client engagements within the Collective Experience as we are not pursuing that segment in order to focus on Web 3 technologies and powering the Metaverse.

 

The consolidated financial statements and related disclosures as of and for the three and six months ended June 30, 2023, are unaudited, pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC"). The consolidated balance sheet as of December 31, 2022 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. In our opinion, these consolidated financial statements include all adjustments (consisting only of normal recurring adjustments) necessary for the fair statement of the results for the interim periods. These consolidated financial statements should be read in conjunction with the consolidated financial statements included in our Annual Report for the year ended December 31, 2022, filed on Form 10-K with the SEC on March 31, 2023. The results of operations for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the full year.

v3.23.2
Note 2 - Recent Accounting Pronouncements
6 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Accounting Standards Update and Change in Accounting Principle [Text Block]

Note 2: Recent Accounting Pronouncements

 

In June 2016, the Financial Accounting Standards Board issued ASU No. 2016-13, "Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" and subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04 and ASU 2019-05 (collectively, “Topic 326”). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. The Company adopted Topic 326 on January 1, 2021 and the adoption had no impact on the Company’s consolidated financial statements. The Company reviewed other newly issued accounting pronouncements and concluded that they either are not applicable to the Company's operations or that no material effect is expected on the Company's financial statements upon future adoption.

 

v3.23.2
Note 3 - Stock-based Compensation
6 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

Note 3: Stock-Based Compensation

 

Our stock-based compensation plan was originally established in 2008. The shares of our common stock issuable pursuant to the terms of such plan (the “Plan Shares”) could not exceed 30% of any outstanding issue or 2,500,000 shares, whichever was the lower amount.

 

In December 2015, we adopted a revised share option plan in which Plan Shares cannot exceed 10% of the total issued and outstanding shares at any given time. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of the grant and all option grants have a 10-year term. This share option plan was initially approved by the Company’s shareholders at the annual meeting of shareholders on August 10, 2016 and is required to be re-approved at each subsequent annual meeting of the Company’s stockholders since that date, in accordance with applicable TSX-V rules.

 

To calculate the fair value of stock options at the date of grant, we use the Black-Scholes option pricing model. The volatility used is based on a blended historical volatility of our own stock and similar sized companies due to the limited historical data available for our own stock price. The expected term was determined based on the simplified method outlined in Staff Accounting Bulletin No. 110. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

 

 

The following table summarizes our stock option activity for the six months ended June 30, 2023:

 

           

Weighted

   

Average

         
           

Average

   

Remaining

   

Aggregate

 
   

Number of

   

Exercise

   

Contractual

   

Intrinsic

 
   

Shares

   

Price

   

Term (in years)

   

Value

 

Outstanding at December 31, 2022

    690,000     $ 0.23       2.63       -  

Granted

    -                          

Exercised

    -                          

Forfeited or expired

    -                          

Outstanding at June 30, 2023

    690,000     $ 0.23       2.20     $ -  
                                 

Exercisable at June 30, 2023

    690,000     $ 0.23       2.20     $ -  

 

As of June 30, 2023, 690,000 stock options were exercisable and all were vested. There was no unrecognized compensation expense from stock options as of June 30, 2023.

 

There were no options granted during the six months ended June 30, 2023.

v3.23.2
Note 4 - Going Concern
6 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Substantial Doubt about Going Concern [Text Block]

Note 4: Going Concern

 

The accompanying consolidated financial statements and notes have been prepared assuming that the Company will continue as a going concern.

 

We have had material operating losses and have not yet created positive cash flows for a full fiscal year. These factors raise substantial doubt as to our ability to continue as a going concern.

 

On August 3, 2020, the Company completed the sale of all of the membership interests in McorpCX, LLC, from which it received proceeds of $1,108,000, consisting of $352,000 in cash and a $756,000 promissory note, reflected on the Company’s financial statements as a “note receivable – related party”. Pursuant to the note receivable, the Company has received $20,000 monthly payments of principal and interest from the purchaser of McorpCX, LLC, which we have relied on to fund our operating costs. As of June 30, 2023, the balance on the note receivable, which matures on December 31, 2023, is $115,588. The $20,000 monthly payments to the Company under the note receivable will end on December 31, 2023.

 

On January 23, 2023 the Company borrowed $20,000 from Gregg Budoi, Interim Chief Financial Officer, and entered into an unsecured Promissory Note that bears interest at the rate of 7%. The accrued interest and outstanding principal balance is due in one lump sum on September 20, 2023.

 

After payment on September 30, 2023 of the $20,000 due under the unsecured Promissory Note, plus accrued interest, held by our Interim Chief Financial Officer, and without the $20,000 in monthly income from the note receivable which ceases on December 31, 2023, the Company believes it does not have sufficient capital to cover our operating costs for the next 12 months, and is seeking ways to raise capital to support operating costs for that period. Therefore, our ability to continue as a going concern is entirely dependent upon our ability over the next 12 months to achieve a level of profitability, and/or to raise additional capital through debt financing and/or through sales of common stock. We cannot provide any assurance that profits from operations, if any, will generate sufficient cash flow to meet our working capital needs and service our existing obligations, nor that sufficient capital can be raised through debt or equity financing. The consolidated financial statements do not include adjustments related to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should we be unable to continue as a going concern.

v3.23.2
Note 5 - Basic and Diluted Net Income / (Loss) Per Share
6 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Earnings Per Share [Text Block]

Note 5: Basic and Diluted Net Income / (Loss) per Share

 

Net income (loss) per share was computed by dividing the net income (loss) by the weighted average number of common shares outstanding during the period. The weighted average number of shares was calculated by taking the number of shares outstanding and weighting them by the amount of time that they were outstanding. For the three and six months ended June 30, 2023 and 2022, the assumed exercise of share options is anti-dilutive and are excluded from the determination of net income (loss) per share – basic and diluted. The share options were anti-dilutive due to the Company’s net loss or the Company’s common stock average market price was less than the share options exercise price. Accordingly, net income/(loss) per share basic and diluted are equal in all periods presented. Securities that were not included in the diluted per share calculations because they would be anti-dilutive were options to purchase common stock of 690,000 and 690,000 for the six months ended June 30, 2023 and 2022, respectively.

v3.23.2
Note 6 - Related Party Transaction
6 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]

Note 6: Related Party Transaction

 

On January 23, 2023 the Company borrowed $20,000 from the Interim Chief Financial Officer and entered into an unsecured Promissory Note that bears interest at the rate of 7%. The accrued interest and outstanding principal balance is due in one lump sum on September 20, 2023.

 

v3.23.2
Note 3 - Stock-based Compensation (Tables)
6 Months Ended
Jun. 30, 2023
Notes Tables  
Share-Based Payment Arrangement, Activity [Table Text Block]
           

Weighted

   

Average

         
           

Average

   

Remaining

   

Aggregate

 
   

Number of

   

Exercise

   

Contractual

   

Intrinsic

 
   

Shares

   

Price

   

Term (in years)

   

Value

 

Outstanding at December 31, 2022

    690,000     $ 0.23       2.63       -  

Granted

    -                          

Exercised

    -                          

Forfeited or expired

    -                          

Outstanding at June 30, 2023

    690,000     $ 0.23       2.20     $ -  
                                 

Exercisable at June 30, 2023

    690,000     $ 0.23       2.20     $ -  
v3.23.2
Note 3 - Stock-based Compensation (Details Textual) - shares
6 Months Ended 12 Months Ended
Aug. 10, 2016
Jun. 30, 2023
Dec. 31, 2008
Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum 10.00%   30.00%
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)     2,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares)   690,000  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)   0  
Share-Based Payment Arrangement, Option [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period 10 years    
v3.23.2
Note 3 - Stock-based Compensation - Stock Option Activity (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Options outstanding, balance (in shares) 690,000  
Weighted average exercise price, outstanding balance (in dollars per share) $ 0.23  
Weighted average remaining contractual term, outstanding balance (Year) 2 years 2 months 12 days 2 years 7 months 17 days
Aggregate intrinsic value, outstanding balance $ 0 $ 0
Granted (in shares) 0  
Exercised (in shares) 0  
Forfeited or expired (in shares) (0)  
Options outstanding, balance (in shares) 690,000 690,000
Weighted average exercise price, outstanding balance (in dollars per share) $ 0.23 $ 0.23
Options exercisable (in shares) 690,000  
Weighted average exercise price, options exercisable (in dollars per share) $ 0.23  
Weighted average remaining contractual term, options exercisable (Year) 2 years 2 months 12 days  
Aggregate intrinsic value, options exercisable $ 0  
v3.23.2
Note 4 - Going Concern (Details Textual) - USD ($)
4 Months Ended 6 Months Ended 12 Months Ended
Aug. 03, 2020
Jun. 30, 2023
Dec. 31, 2023
Jan. 23, 2023
Dec. 31, 2022
Unsecured Promissory Note [Member] | Chief Executive Officer [Member]          
Debt Instrument, Face Amount       $ 20,000  
Chief Financial Officer [Member] | Unsecured Promissory Note [Member]          
Monthly Proceeds From Divestiture of Interest in Consolidated Subsidiaries     $ 20,000    
Debt Instrument, Face Amount         $ 20,000
Debt Instrument, Interest Rate, Stated Percentage       7.00%  
Discontinued Operations, Disposed of by Sale [Member] | McorpCX [Member]          
Proceeds from Sale of Intangible Assets $ 1,108,000        
Cash, Ending Balance 352,000        
Receivable with Imputed Interest, Face Amount $ 756,000 $ 115,588      
Discontinued Operations, Disposed of by Sale [Member] | McorpCX [Member] | Forecast [Member]          
Monthly Proceeds From Divestiture of Interest in Consolidated Subsidiaries     $ 20,000    
Discontinued Operations, Disposed of by Sale [Member] | McorpCX [Member] | Related Party [Member]          
Monthly Proceeds From Divestiture of Interest in Consolidated Subsidiaries   $ 20,000      
v3.23.2
Note 5 - Basic and Diluted Net Income / (Loss) Per Share (Details Textual) - shares
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) 690,000 690,000
v3.23.2
Note 6 - Related Party Transaction (Details Textual) - Chief Financial Officer [Member] - Unsecured Promissory Note [Member]
Jan. 23, 2023
USD ($)
Debt Instrument, Face Amount $ 20,000
Debt Instrument, Interest Rate, Stated Percentage 7.00%

MCX Technologies (CE) (USOTC:MCCX)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more MCX Technologies (CE) Charts.
MCX Technologies (CE) (USOTC:MCCX)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more MCX Technologies (CE) Charts.